{"id":"NCT01568866","sponsor":"Amgen","briefTitle":"Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients","officialTitle":"A Randomized, Open-label, Phase 3 Study of Carfilzomib Plus Dexamethasone vs. Bortezomib Plus Dexamethasone in Patients With Relapsed Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06-20","primaryCompletion":"2014-11-10","completion":"2018-02-05","firstPosted":"2012-04-02","resultsPosted":"2015-12-11","lastUpdate":"2022-11-14"},"enrollment":929,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Carfilzomib","otherNames":["PR-171","Krypolis"]},{"type":"DRUG","name":"Bortezomib","otherNames":["Velcade"]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]}],"arms":[{"label":"Carfilzomib plus Dexamethasone","type":"EXPERIMENTAL"},{"label":"Bortezomib plus Dexamethasone","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this study was to compare progression-free survival in patients with multiple myeloma who relapsed after 1 to 3 prior therapies treated with carfilzomib plus dexamethasone or bortezomib plus dexamethasone.","primaryOutcome":{"measure":"Progression-free Survival","timeFrame":"From randomization until the data cut-off date of 10 November 2014; median follow-up time for PFS was 11.1.and 11.9 months in the bortezomib and carfilzomib arms respectively","effectByArm":[{"arm":"Bortezomib + DEX","deltaMin":9.4,"sd":null},{"arm":"Carfilzomib + DEX","deltaMin":18.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":241,"countries":["United States","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Czechia","France","Germany","Greece","Hungary","Israel","Italy","Japan","New Zealand","Poland","Romania","Russia","Singapore","Slovakia","South Korea","Spain","Taiwan","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":["27491641","28025582","28843768","28306371","29991494","30478094","33166401","28439109","30287200","30796199","29446103","32108443","31388932","28937327","29027825","33067574","31640435","31160237","30610657","26771810","26671818"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":182,"n":456},"commonTop":["DIARRHOEA","ANAEMIA","FATIGUE","INSOMNIA","PYREXIA"]}}